Tate & Lyle’s sour M&A may have nicer aftertaste
Corrects first paragraph to state that Tate & Lyle is a former rather than current sugar producer. The author is a Reuters Breakingviews columnist. The opinions expressed are her own.
By Aimee Donnellan
LONDON, June 20 (Reuters Breakingviews) -Tate & Lyle’s TATE.L latest spot of M&A may be more appetising than it looks. On Thursday, the $3.2 billion former cane sugar producer splurged $1.8 billion on ingredient business CP Kelco. A 7% fall in the buyer’s shares suggests investors may be focusing on sour returns. But the deal’s strategic logic may yet provide a pleasant aftertaste.
Tate & Lyle CEO Nick Hampton is coming to the end of his transformation plan. Hampton, who took over in 2018, has been shifting the business away from its commodity past and focusing it more on “clean label” ingredients that are not considered artificial additives. Last month, he also flogged his remaining stake in plant-based ingredient maker Primient, raising $1.5 billion in the process to bolster the company’s balance sheet and allow it to do a deal like CP Kelco.
Buying an ingredients business with better exposure to large growth markets like China and Latin America makes sense. And buying CP Kelco’s pectin-based ingredients can help offset the key flaw with clean label ingredients – they don’t taste as nice. Low-fat yogurts, for example, often have an unappetising consistency due to the loss of fat and sugar.
Some of the reasons for Thursday’s share price slide aren’t deal-related: Tate & Lyle paid a dividend on Thursday, and it is also part-paying for CP Kelco by giving owner J.M. Huber a 16% share in its business by issuing equity, which dilutes current investors. Yet the deal’s returns still look underwhelming.
Last year, CP Kelco’s revenue dropped 3% and its adjusted operating profit fell 26% to $62 million. Add $50 million of expected cost synergies and tax them at 22%, and the $1.8 billion outlay only yields a 5% return. That’s a long way from Tate & Lyle’s 9% cost of capital, a rough proxy for the target’s.
Yet Hampton can argue CP Kelco is in a temporary slump. Inflationary pressures are easing, which may encourage consumers to spend more. Supply chain disruptions also hit revenue and profits. Imagine sales grow at around 9% next year, the level achieved in 2021, and CP Kelco musters the 23% EBITDA margin it made that year. Lop off $69 million of depreciation and amortisation and add the synergies, and next year’s return would be near 8%. Fold in the strategic logic, and Tate & Lyle’s latest gambit has at least a path to passing the taste test.
Follow @aimeedonnellan on X
CONTEXT NEWS
Britain’s $3.2 billion food ingredients maker Tate & Lyle said on June 20 it had entered into an agreement to buy CP Kelco, a leading provider of pectin and speciality gums, for $1.8 billion from privately held U.S. group J.M. Huber Corporation.
Tate, one of the world’s biggest producers of sweeteners, expects to generate $50 million of cost synergies in the second full financial year following completion of the deal. It also expects to generate revenue synergies of up to 10% of CP Kelco’s sales over the medium term.
Tate will finance the deal with $1.15 billion of cash and $645 million of new shares issued to J.M. Huber.
Tate & Lyle shares were down 7% at 630 pence as of 0952 GMT on June 20.
Graphic: Tate & Lyle’s performance under its current CEO https://reut.rs/3zdsD7d
Editing by George Hay and Oliver Taslic
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
